SelectScience
Join Free
Accelerating Science
NewsDrug discovery > Target Discovery

LG Chem Life Sciences Expands Partnership with Avacta Group plc

Avacta Group plc

LG Chem selects second and third drug targets following rapid progress in first program

18 Nov 2019
Jay Leech
Marketing / Sales

Industry news

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, has provided an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences (LG Chem), part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas.

Avacta has successfully generated a large number of Affimer proteins that bind to the first drug target nominated by LG Chem. These candidate Affimer molecules are now being optimized by Avacta, for LG Chem to then carry out pre-clinical development, successful completion of which would trigger the next substantial milestone payment to Avacta.

LG Chem has now expanded the collaboration by nominating the second and third drug targets and Avacta is beginning the discovery programs for Affimer binders to those new targets. Each of these programs also has the potential for further milestone payments.

The multi-target therapeutics development agreement with LG Chem was signed in December 2018 and provided upfront and near-term development milestone payments, plus longer-term clinical development milestones. Avacta will also receive royalties on any future product sales and LG Chem is covering all Avacta’s costs of research and development associated with the collaboration.

Alastair Smith, Chief Executive Officer of Avacta Group plc, commented: “I am very pleased with the excellent progress made in the first program with LG Chem. Not only is this an important validation of the Affimer platform, confirming that it can be used to quickly generate potential candidate drug molecules for development, but it also means that we have taken an important step towards receiving the next substantial milestone payment under our collaboration agreement. Our partnership with LG Chem goes from strength to strength with their decision to nominate the next two drug targets. I look forward to keeping the market informed of further progress over the coming months.”

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Avacta Group plc

Tags

Sample PreparationSample preparation can improve the quality and speed of separation techniques. Products to assist sample preparation include filtration equipment, evaporators, membranes and sieves.Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.CollaborationDrug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.Drug Discovery & Development Screening

Related articles

LG Chem Life Sciences Expands Partnership with Avacta Group plc